Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell Dev. Biol.

Sec. Molecular and Cellular Pathology

Volume 13 - 2025 | doi: 10.3389/fcell.2025.1627985

This article is part of the Research TopicElucidating the Role of Calcium Signaling in Cardiac DisordersView all articles

Altered endoplasmic reticulum calcium loading in human PLN R14del cardiomyopathy

Provisionally accepted
Willem  BorbeinWillem BorbeinLukas  DahmlosLukas DahmlosUmber  SaleemUmber SaleemMarina  ReinschMarina ReinschIngke  BrarenIngke BrarenThomas  SchulzeThomas SchulzeBirgit  KlampeBirgit KlampeFriederike  CuelloFriederike CuelloJustus  StenzigJustus StenzigThomas  EschenhagenThomas EschenhagenArne  HansenArne Hansen*
  • University Medical Center Hamburg-Eppendorf, Hamburg, Germany

The final, formatted version of the article will be published soon.

The phospholamban (PLN) R14del genetic variant causes dilated cardiomyopathy. Previous studies suggest involvement of the ER stress response and impairment of ER-related signalling pathways such as autophagy. In this study, human induced pluripotent stem cell-derived cardiomyocytes from an unrelated control subject, PLN R14del patient and corresponding isogenic control were transduced with AAV6 encoding the endoplasmic reticulum calcium sensor CEPIAer. Indicator compounds for modulation of ER calcium homeostasis showed similar characteristic effects on CEPIAer fluorescence intensity in engineered heart tissues from all three cell lines, validating CEPIAer fluorescence intensity as a surrogate for ER calcium loading. Cytoplasmic calcium loading induced by high extracellular calcium concentration revealed subtle alterations in PLN R14del consistent with higher ER calcium loading. FACS analyses of dissociated cardiomyocytes confirmed higher ER calcium load. Taken together, this study provides evidence for altered ER calcium loading as a new disease mechanism in PLN R14del cardiomyopathy.

Keywords: Phospholamban R14del, Human Induced Pluripotent Stem Cells, Engineered heart tissue, Endoplasmic Reticulum, CEPIAer

Received: 13 May 2025; Accepted: 07 Jul 2025.

Copyright: © 2025 Borbein, Dahmlos, Saleem, Reinsch, Braren, Schulze, Klampe, Cuello, Stenzig, Eschenhagen and Hansen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Arne Hansen, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.